Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $22.02, but opened at $22.97. Acadia Healthcare shares last traded at $24.22, with a volume of 548,093 shares changing hands.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the stock. Raymond James Financial reaffirmed an "outperform" rating and issued a $26.00 price target (down previously from $40.00) on shares of Acadia Healthcare in a report on Thursday, August 14th. UBS Group lowered their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Cowen reaffirmed a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Finally, Stephens raised shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Eight investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $39.00.
Check Out Our Latest Stock Report on Acadia Healthcare
Acadia Healthcare Trading Up 8.8%
The company has a market capitalization of $2.21 billion, a PE ratio of 15.85, a price-to-earnings-growth ratio of 4.53 and a beta of 0.89. The company's fifty day moving average is $21.81 and its 200-day moving average is $23.71. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period in the previous year, the company earned $0.91 earnings per share. The business's revenue for the quarter was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.
Institutional Investors Weigh In On Acadia Healthcare
Large investors have recently made changes to their positions in the stock. Verdence Capital Advisors LLC raised its position in shares of Acadia Healthcare by 3.3% in the second quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company's stock worth $333,000 after acquiring an additional 465 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after acquiring an additional 497 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Acadia Healthcare by 10.3% in the first quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock worth $202,000 after acquiring an additional 622 shares during the period. LPL Financial LLC raised its position in shares of Acadia Healthcare by 1.2% in the first quarter. LPL Financial LLC now owns 56,527 shares of the company's stock worth $1,651,000 after acquiring an additional 697 shares during the period. Finally, UMB Bank n.a. raised its position in shares of Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after acquiring an additional 755 shares during the period.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.